Financial News

• Placement of a promissory note loan of EUR 580 million • Sales increase to more than EUR 2.3 billion • EBITDA rises by around 13% to EUR 265 million • Outlook confirmed: Organic sales growth in 2015 of between 2% and 4%

• Hospital group successfully concludes one of the largest ever promissory note issues in the healthcare sector • Return to promissory note market for first time since 2013 – oversubscribed several times over • Favourable conditions boost earnings power and open up financial flexibility for corporate strategy • Average term of eight years; terms on individual tranches of up to 15 years improve Group’s maturity profile

Asklepios continued to grow in line with its targets in the first half of 2015. Asklepios again saw increases in both revenue and operating earnings, expanding its position as one of the leading private clinic operators in Germany.

The healthcare group Asklepios Kliniken GmbH started the 2015 financial year successfully, as shown by the interim report as of 31 March, published today. The company, founded 30 years ago in June 1985, therefore continued the positive development of the previous year. Between January and March, the Group’s hospitals treated 558,690 patients, 2.9% more than in the same quarter of the previous year (3M 2014: 542,741 patients). Revenue increased to EUR 774.1 million (3M 2014: EUR 753.7 million); the purely organic growth amounted to 2.7%. While the number of beds was largely stable (-0.1% to 26,550 beds), the number of employees grew by 0.6% to 34,396 full-time equivalents. Utilisation increased from 83.9% in the same quarter of the previous year to 85.4% in the first quarter of 2015.